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Abstract
Non-steroidal anti-inflammatory drugs (NSAID) are a class of medications used
in the treatment of pain, inflammation, and illness. These medications are common,
affordable, and easy to access. For these reasons, NSAIDs are commonly used by
athletes of all backgrounds for treating injuries and as ergogenic aids. However, despite
these behaviors, NSAIDs have well-documented side effects and the efficacious nature of
these medications has been brought into question. Despite this, many athletes continue to
use these medications frequently and indiscriminately. It is not known why athletes use
these medications in light of their questionable effectiveness and cited adverse effects.
Therefore, this study was designed to (1) further investigate the prevalence of NSAID use
in collegiate-level athletes, (2) investigate attitudes and behaviors toward the use of
NSAIDs cross-tabulated by sport, gender, and competition level, and (3) investigate
athletes’ general knowledge of NSAIDs.
Subjects for this study included 79 student-athletes (44 male; 25 female) attending
Portland State University (PSU). The majority of the athletes started taking NSAIDs
before high school (72% of the males and 64% of the females). Thirty-three percent of
males and 32% of females reported that they had been taking NSAIDs within the past
week. High in-season use of NSAIDs was reported by 52% of the male athletes and 48%
of the female athletes, whereas off-season use was reported by 21% and 12% of the males
and females, respectively. Cited reasons for NSAID use both in-season and off-season
were relief of pain due to injury, prevention, recovery, soreness, and tightness. In total,
83% of males and 76% of females reported obtaining NSAIDs primarily through means
i

other than health-care professionals. With regard to dosage, athletes reported taking
NSAIDs based on product directions, instructions of an athletic trainer or perceived pain
levels. An overwhelming majority of athletes (83% male; 76% female) were not aware
of any side-effects from taking NSAIDs
In summary, this study revealed a pattern of high NSAID use in athletes
competing in-season compared to a high prevalence of low NSAID use in athletes offseason. It also revealed a high prevalence of non-prescription NSAID use. Additionally,
there was a high prevalence of self-purchasing of NSAIDs, combined with selfmedication and a long history of NSAID use. This study also revealed a general lack of
knowledge about NSAIDs.
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Glossary
Cyclooxygenase (COX): Enzyme responsible for the formation of prostaglandins.

Delayed Onset Muscle Soreness (DOMS): Pain and stiffness felt in muscles several
hours to days after unaccustomed or strenuous exercise.

Inflammation: The body’s initial response to harmful stimuli, which quarantines the area
and initiates the healing process. Symptoms of inflammation include pain, redness,
swelling, heat, and loss of function.

Non-Steroidal Anti-Inflammatory Drugs (NSAID): Medications that have analgesic
(pain relieving), antipyretic (fever-reducing), antithrombotic (blood-thinning), and antiinflammatory properties. These drugs can either be prescribed or purchased over-thecounter (OTC).

Over-the-Counter (OTC): Medications that can be purchased and administered without
a prescription.

Prophylactic: Guarding from or preventing the spread or occurrence of something.

Prostaglandins (PG): Fatty acid derivatives that are important in the regulation of
inflammation
vii

Chapter 1
Introduction
Introduction
Competitive athletes at all levels typically put in a great deal of time and effort to
meet the physical demands of their sports. While athletes work to meet these demands,
their bodies are at increased risk of injury. In 2002, 20.3 million sports-related injuries
were estimated to have occurred in the U.S., or 70.5 injuries per 1000 persons (Warden,
2005). Because athletic endeavors are associated with a high amount of physical stress
and injury, athletes rely on various methods to help minimize possible negative effects of
training and competition.
One of the most popular methods used by athletes to assist with athletic-ailments
is the use of non-prescription pain relievers, specifically, non-steroidal anti-inflammatory
drugs (NSAID) (Lanier, 2004; Ziltener, Leal, & Fournier, 2010). NSAIDs are a class of
analgesic (pain relieving) medications used in the treatment of pain, inflammation, and
illness. NSAIDs are well-known for being relatively cheap and easy to access as most of
these medications can be purchased over-the-counter (OTC) at various general stores and
pharmacies. NSAIDs are not only popular with athletes due to their affordability and
ease of access, but also due to the social acceptability of their use, their ease of
administration, and high amounts of observed use by peers (clinicians, parents, friends,
siblings, etc.) (Holmes, Cronholm, Duffy, & Webner, 2013; Warner, Schnepf, Barrett,
Dian, & Swigonski, 2002). Thus, NSAIDs are used at one’s leisure without fear of
repercussions or stigmatization (Holmes et al., 2013; Warner et al., 2002). It is for these
1

reasons, NSAIDs are a popular drug of choice for athletes treating painful
musculoskeletal injuries, chronic inflammatory conditions, and looking to increase
athletic performance (Correa et al., 2012; Da Silva et al., 2011).
Statement of Problem
While NSAIDs are a staple medication for the treatment of sports injuries and
inflammatory conditions, it is well-known that these medications can have serious sideeffects (Moore, 2007; Paoloni et al., 2010; Warden, 2010; Ziltener et al., 2010).
Additionally, the efficacy of NSAIDs has been highly debated over the last couple of
decades, thus putting into question whether these drugs work as they are intended to
(Correa et al., 2012; Hasson et al., 1993; Yamamoto et al., 1999). It has also been
reported that misuse and lack of knowledge in relation to NSAIDs is high amongst
athletes (Corrigan & Kazlauskas, 2003; Da Silva et al., 2011; Holmes et al., 2013;
Warner et al., 2002). Furthermore, clinicians working with athletes vary on their
educational understanding of NSAIDs, therefore, prescription and dispensing of these
medications is inconsistent (Holmes et al., 2013; Lanier, 2004; Van Wijck et al., 2012).
Because of these reasons and their commonality and acceptability in society, athletes
worldwide continue to use these medications indiscriminately without proper supervision
or education, thus putting them at a higher risk for experiencing adverse events.
Purpose
Currently, there is limited research on NSAID use within diverse athletic
populations, such as colleges, universities, and secondary schools. While a handful of
studies have shed light on the prevalence of NSAID use in athletic populations (Berglund
2

& Sundot-Borgen, 2001; Da Silva et al., 2011; Holmes et al., 2013; Warner et al., 2002)
few studies have investigated knowledge, behaviors, and attitudes (Warner et al., 2002)
associated with NSAID use. It can be hypothesized that athletes would likely limit their
use of NSAIDs if they were educated about the proper use and potential side-effects
associated with these medications, however, more research is needed on a diverse range
of athletes to test this hypothesis. Therefore, it is the duty of health-care professionals
and researchers alike to investigate how NSAID use differs between competition level,
sport, gender, age, and social background. Doing so can help provide insight as to why
athletes continue to indiscriminately use NSAIDs despite their well-noted side-effects
and questionable effectiveness. Having this information can help facilitate the
implementation of policies and programs that can educate athletes about the proper use of
these medications, increase regulations around ease of access, and further advance the
field of sports medicine.
For these reasons this study was designed to (1) further investigate the prevalence
of NSAID use in a collegiate-level athletes, (2) investigate attitudes and behaviors toward
the use of NSAIDs cross-tabulated by sport, gender, and competition level, and (3)
investigate athletes’ general knowledge of NSAIDs.

3

Chapter 2
Review of Literature
This literature review was conducted using the Portland State University Library
online database system. Research literature was found using science and health databases
such as Health Source, MEDLINE, EBSCO, PubMed, SPORTDiscus, and Web of
Science. The keywords NSAIDs, athletes, non-steroidal anti-inflammatory drugs,
analgesics, pain relieving drugs, sports and pain medication, over-the-counter pain
medication, and performance enhancing drugs were used to help locate relevant
published research.
General Information on NSAIDs
Early studies show that 30% of adults have used one or more nonprescription
medications in the previous 48 hours (Bush & Rabin, 1976), while more than 50% of
children have taken non-prescription medications within the same time frame (Kohn &
White, 1976). A more recent study found up to 75% of adolescents use non-prescription
medications without consulting an adult (Chambers, Reid, McGrath, & Finley, 1997). Of
these non-prescription medications, analgesics such as non-steroidal anti-inflammatory
drugs (NSAID) are the most commonly used (Warner et al., 2002).
NSAIDs are a class of medications used in the treatment of acute and chronic
pain. They are among the most commonly used medications with a worldwide market of
over $6 billion each year (Wallace, 1997). Most NSAIDs are categorized as
cyclooxygenase (COX) inhibitors and thus exert their effects through acting on one of
two main COX isozymes named COX-1 and COX-2 (Warden, 2005). Commonly
referred to as the “housekeeping” isoform, COX-1 garners this title due to its structural
4

features and its predominantly constitutive expression (Vane & Botting, 1998). COX-2,
on the other hand, is referred to as the inducible isoform because it is brought about in
response to a variety of stimuli (Vane & Botting, 1998). NSAIDs that inhibit the COX-1
isozyme represent the bulk of the market and are the only type of NSAIDs that can be
purchased “over-the-counter”, whereas NSAIDs that inhibit the COX-2 isozyme are
typically only obtained via prescription from a medical professional.
The therapeutic effects of NSAIDs are made possible through the prevention of
prostaglandin (PG) synthesis via the inhibition of the COX enzyme (Vane, 1971). Most
NSAIDs accomplish this by reversibly inhibiting COX by competing with the substrate
arachidonic acid for the active site of the enzyme, thereby preventing the conversion of
arachidonic acid to PG (Vane, 1971; Vane & Botting, 1998). Other NSAIDs—such as
aspirin—act differently; they inhibit prostaglandin synthesis through the irreversible
acetylation of COX (Lieber & Friden, 2002).
NSAID Use in Athletic Populations
There were an estimated 20.3 million sports-related injuries in the US during the
year 2002, which is approximately 70.5 injuries per 1000 persons (Warden, 2005). There
are only a handful of published studies on the prevalence of NSAID use in athletes, but a
growing awareness of the extent of NSAID consumption in the sporting world has begun
to emerge in the last decade. Reports document a high prevalence of NSAID use across a
variety of athletes, ranging from youth sports to elite Olympic athletes (Alaranta,
Alaranta, & Helenius, 2008; Holmes et al., 2013; Tscholl, Junge, & Dvorak, 2008;
Tscholl, Alonso, Dolle, Junge, & Dvorak, 2010; Warner et al., 2002). Survey studies
5

investigating NSAID use in high-level international athletes have found this class of
medication to be the most frequently used (Corrigan & Kazlauskas, 2003; Huang,
Johnson, & Pipe, 2006; Taioli, 2007; Tscholl et al., 2008). While daily NSAID use in the
general population is reported to be around 1-4% (Barozzi & Tett, 2008; Leufkens,
Ameling, Hekster, & Bakker, 1990), the reported daily use of NSAIDs by elite Olympic
athletes and international soccer players is as high as 25-35% (Corrigan & Kazlauskas,
2003; Huang et al., 2006; Tscholl et al., 2008). Data from other studies indicate a wide
range of NSAID use in different sports, ranging from 12% in cyclists to more than 90%
in professional soccer players (Gorski et al., 2011; Taioli, 2007; Thuyne & Delbeke,
2008). Reports have also found concomitant use of up to five different anti-inflammatory
agents in approximately 10% of high-level athletes (Corrigan & Kazlauskas, 2003;
Tscholl et al., 2008).
In a study of 1261 international athletes at the 2007 Pan-American Games, Da
Silva et al. (2011) found that 63% (n = 792) of the athletes were using NSAIDs. Of those
athletes that were currently competing in their sport (n = 1030), 65% (n = 670) were
using NSAIDs. Of those athletes that were not competing in their sport (n = 231), 56%
(n = 129) were using NSAIDs. This study confirmed previous observations of high
NSAID use in athletes while in-competition, but also demonstrated high use while out of
competition. Furthermore, this study observed that higher use of NSAIDs while incompetition than out of competition suggests that some athletes may use these
medications as ergogenic aids.
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Berglund and Sundot-Borgen (2001) interviewed approximately 500 Swedish
Olympic athletes participating from 1996-2000. In their study they found NSAID use
was approximately six- to ten-fold higher than in the general population of the same age.
Huang et al. (2006) studied approximately 500 Olympic athletes from the 1996 and 2000
Olympic Games where NSAID use was reported as high as 38%, with the highest usage
patterns exhibited by softball (60% of participants) and gymnastics (100% of
participants). Corrigan and Kazlauskas (2003) found that 26% of athletes at the 2000
Sydney Olympics reported NSAID use within the previous three days. It was also noted
that inappropriately high doses and concomitant use of several different NSAIDs were
common amongst those athletes.
Holmes et al. (2013) conducted a recent study in which they surveyed 211 NCAA
Division I and Division III football athletes on the prevalence of NSAID use in a
collegiate football setting. Of the athletes surveyed, 96% had used NSAIDs at some
time. Players reported initial use of NSAIDs as early as junior high (46%) and high
school (49%), whereas only 5% started taking NSAIDs in college. Athletes also reported
receiving NSAIDs from a variety of sources during the year: self (81.0%), parents
(54.5%), trainers (29.9%), physicians (27.0%), teammates (5.7%), and coaches (1.4%).
They also found that 50.0% of participants reported high NSAID use during the season,
compared to 14.6% during the off-season. This means athletes were signiﬁcantly more
likely to use NSAIDs during the in-season if they reported off-season use. The study
further examined NSAID use before, during, and after practices and games. Responses
were dichotomized into low (never and sometimes) and high usage (usually and always)
7

categories. Before games, 10.9% of the athletes reported high use of NSAIDs, while only
0.5% reported high use during games, and 32.7% reported high use after games. This
study demonstrated high prevalence of NSAID use among collegiate football players and
also demonstrated high rates of self-medication and parental sourcing of NSAIDs,
presumably without knowledge of the medical team (i.e., athletic trainers and
physicians).
Joslin, Lloyd, Kotlyar, and Wojcik (2013) investigated NSAID usage patterns
between ultra-distance (UD) marathon runners and regular-distance (RD) marathon
runners. They looked at usage patterns during training, during competition, and during
recovery. Out of 73 athletes that were surveyed (27 UD and 46 RD), 70% of UD runners
used NSAIDs during competition, while 59% used during training, and 59% used during
recovery. The NSAID usage pattern for RD runners was 26% during competition, 63%
during training, and 61% during recovery. There was a high prevalence of NSAID use in
both types of runners, especially during training.
Reasons for Use in Athletes
Due to the high physical demands, intensity, contact, and repetitive movements of
competitive sports, there is a high frequency of physical trauma (Da Silva, 2011). It is
for these reasons—accompanied by their anti-inflammatory and analgesic properties and
their universal availability—that NSAIDs have seen widespread use among athletes of all
ages (Lanier, 2004; Ziltener et al., 2010). It is also thought the negative association
between pain and the ability to perform in athletic competition may mean athletes use
NSAIDs to improve performance (Correa et al., 2012; Da Silva et al., 2011). Another
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possible reason for the use of NSAIDs by athletes is an attempt to minimize the degree of
pain and inﬂammation that occurs from the repetitive practice of sport (Da Silva et al.,
2011). It is generally believed that the inflammatory process and the accumulation of
muscle edema following unaccustomed exercise contributes to the development of
delayed onset muscle soreness (DOMS). As a result, both prophylactic and therapeutic
use of NSAIDs for the treatment of DOMS has been observed in athletes (Alaranta et al.,
2008; Lanier, 2004; Tscholl et al., 2010; Warden, 2009; Warden, 2010; Warner et al.,
2002; Ziltener et al., 2010).
Warner et al. (2002) performed a study in which they surveyed NSAID use in
high school football players. A total of 604 players returned completed surveys; 452
players (75%) reported using NSAIDs in the previous months for reasons related to their
sport, while 90 players (15%) described daily use of NSAIDs. Daily NSAID users were
more likely to feel an advantage in taking NSAIDs than a disadvantage, in order to block
pain before it occurred, to administer NSAIDs without supervision, and to decide the
dosage without supervision. Players who perceived that their performance was enhanced
by using NSAIDs, who decided on their own when to administer NSAIDs, and/or used
NSAIDs to stop pain prophylactically rather than after the onset of pain were
significantly more likely to use NSAIDs daily.
This study demonstrated that up to one in seven high school football players
misuse NSAIDs, meaning the use of NSAIDs among high school football players is high,
and the recognition of associated risks is low. This study also found that daily users are
more likely to decide on their own when to use NSAIDs, and to use prophylactically, thus
9

leading to the likelihood that supervising adults are unlikely to be aware of NSAID
misuse.
Efficacy of NSAIDs
NSAIDs have known anti-inflammatory, analgesic, antipyretic and antithrombotic
effects (Paoloni, Milne, Orchard, & Hamilton, 2010). They have also been shown to be
modestly effective in the treatment of pain when compared to a placebo (Almekinders,
1999). Additionally, study reviews looking at the effects of NSAIDs on various maladies
have found NSAIDs to be effective in treating chronic inflammatory conditions such as
rheumatoid arthritis (Paoloni et al., 2010; Warden, 2005). While using NSAIDs for pain
and chronic inflammatory conditions may be indicated, the effectiveness of NSAIDs
outside of these reasons is uncertain.
As mentioned earlier, prophylactic NSAID use is popular amongst athletes trying
to mitigate the effects of DOMS. While using NSAIDs to treat DOMS may seem logical
due to their anti-inflammatory and analgesic properties, the efficacy of NSAID therapy
for the treatment of DOMS in sport is controversial and challenging to review. NSAID
use could contribute to reduced pain as a result of reduced muscle edema; however,
investigations examining this theory are inconsistent, with roughly equal numbers ﬁnding
no effect of NSAIDs on DOMS (Donnelly, McCormick, Maughan, Whiting, & Clarkson,
1988; Donnelly, Maughan, & Whiting, 1990; Grossman, Arnold, Perrin, & Kahler, 1995;
Howell, Conaster, Chleboun, Karapondo, & Chila, 1998a; Howell, Conaster, Chleboun,
Karapando, & Chila, 1998b; Kuipers, Keizer, Verstappen, & Costill, 1985; Peterson et
al., 2003; Pizza, Cavender, Stockard, Baylies, & Beighle, 1999; Semark, Noakes, St.
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Clair Gibson, & Lambert, 1999; Stone, Merrick, Ingersoll, & Edwards, 2002), or a
significant attenuation of DOMS (Baldwin, Stevenson, & Dudley, 2001; Dudley et al.,
1997; Francis & Hoobler, 1987; Hasson et al., 1993; Lapointe, Fremont, & Cote, 2002;
Lecomte, Lacroix, & Montgomery, 1998; Mishra, Friden, Schmitz, & Lieber, 1995;
O’Grady et al., 2000; Sayers, Knight, Clarkson, Van Wegen, & Kamen, 2000;
Tokmakidis, Kokkinidis, Smilios, & Douda, 2003; Trappe, Fluckey, White, Lambert, &
Evans, 2001).
Hasson et al. (1993), investigated the influence of acute doses of ibuprofen in
conjunction with strength training and found decreases in DOMS, but no difference in
creatine kinase (CK) levels. Correa et al. (2012) conducted a recent study examining the
effects of NSAIDs used before resistance exercise. In their study they did not find a
significant difference between the use of ibuprofen or placebo in total strength training
volume or creatine kinase (CK) levels before or after exercise. This suggests that
NSAIDs may reduce soreness due to their analgesic effect, but they do not influence
muscle damage. In light of the controversy surrounding NSAIDs and their effectiveness
in treating DOMS, the potential for adverse effects and the possibility of a negative effect
on recovery may override the use of NSAIDs as modality in the treatment of DOMS
(Barnett, 2006; Peterson et al., 2003).
Other studies have investigated the efficacy of NSAID use for strength training.
Krentz, Quest, Farthing, Quest, and Chilibeck (2008) investigated the effects of ibuprofen
on non-trained males during a six-week strength training program; their results yielded no
evidence of a hypertrophic effect on the subjects. Trappe et al. (2011) found that
11

ibuprofen administration enhanced muscle strength and muscle size during a strength
training regimen in older adults. While these findings require further investigation, it can
be inferred that NSAID treatment may have a positive effect on muscle injury/recovery in
individuals with elevated levels of inﬂammatory cytokines, as is the case for many older
adults (Mackey, Mikkelsen, Magnusson, & Kjaer, 2012).
NSAIDs are commonly used in conjunction with acute and reoccurring muscular
injury, however, whether NSAIDs are beneficial or detrimental to muscular injury
remains unclear (Lanier, 2004; Mackey et al., 2012; Paoloni et al., 2010). Reynolds,
Noakes, Schwellnus, Windt, and Bowerbank (1995) conducted a randomized, doubleblind, placebo-controlled trial on the effects of NSAIDs on acute hamstring injuries.
Both the placebo group and the treatment group received the same physical therapy
routine. Results indicated that reduction of pain and swelling and return to normal
strength were no better with or without NSAIDs. In fact, reduction of pain was better in
the placebo group. Rahusen, Weinhold, & Almekinders (2004) conducted a study
comparing the analgesic effects of NSAIDs vs non-anti-inflammatory analgesics in adult
mice. The results of the study indicated that NSAIDs were no more effective in treating a
muscle contusion than an analgesic without anti-inflammatory effects, such as
acetaminophen. Despite the fact that NSAIDs may be effective at decreasing
inflammation and therefore decreasing pain, analgesics without anti-inflammatory
properties may be just as effective in treating pain related to muscular injury (Rahusen et
al., 2004).
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Human studies examining the effects of NSAIDs on ligament injuries have
demonstrated that NSAIDs are effective at decreasing pain and allowing for a faster
return to activity from acute ankle sprains (Ekman, Fiechtner, Levy, & Fort, 2002;
Mazieres, Rouanet, Velicy, Scarsi, & Reiner, 2005; Moran, 1991; Slayter, Hensley, &
Lopert, 2003). Buvanendran et al. (2003) found that patients treated with COX-2
inhibitors following knee replacement surgery had lower in-hospital narcotic medication
consumption, lower pain scores, greater knee range of motion, and shorter time in
physical therapy than placebo-treated patients. While these studies demonstrate that
NSAIDs can alleviate pain and facilitate a quicker return to normal function with
ligament injuries, they do not determine whether or not there are long-term effects on
tissue-level healing. Furthermore, they do not determine whether the use of NSAIDs
results in ongoing morbidity and/or enhanced injury susceptibility (Warden, 2005).
There are some theories that suggest NSAIDs are incapable of affecting the
peripheral inflammatory response. After soft tissue injury, PGs may be produced rapidly,
before NSAIDs are available to inhibit the COX-PG pathway (Yamamoto et al., 1999).
Also, other inflammatory mediators, such as kinins and histamine, may be present and
allow an inflammatory response to progress without the presence of PGs (Rahusen et al.,
2004).
Adverse Effects
Reviews investigating the various effects of NSAID use in sport have found
several adverse effects such as decreased prostaglandin synthesis in the gastrointestinal
(GI) tract, changes in renal function, peripheral edema, hypertension, and inhibition of
13

renal excretion of water and sodium and hyperkalemia (Alaranta et al., 2008; Moore,
2007; Paoloni et al., 2010; Warden, 2010; Ziltener et al., 2010). These effects may
contraindicate the administration of NSAIDs as an ergogenic agent in such activities as
aerobic and anaerobic training (Correa et al., 2012). Additionally, many believe that the
analgesic effect of NSAIDs can mask the pain of an injury and thus prevent the athlete
from resting long enough to allow for proper healing (Baker, Cotter, Gerrard, Bell, &
Walker, 2005; Warden, 2009).
NSAIDs are anti-inflammatory agents, meaning they are responsible for
decreasing inflammation. In certain circumstances, a decrease in inflammation may be a
desired effect; however, the inflammatory response is a way for the body to clear away
injured cells and tissue, thus initiating a healing response. Therefore, a marked decrease
in the inflammatory response due to the use of NSAIDs may be a detriment to the healing
process and ultimately result in poorer tissue regeneration (Gilroy et al., 1999; Jarvinen,
Lehto, & Sorvari, 1992; Mackey et al., 2012; Rankin, 2004; Warden, 2005; Warden,
2009).
Almekinders and Gilbert (1986) demonstrated via histological examination that
muscle strains in adult rats treated with NSAIDs continue to weaken in the early postacute injury period. Elder, Dahners, and Weinhold (2001) investigated the effects of
COX-2 inhibitors on tissue-level healing in rat ligaments. Ligament injuries treated with
COX-2 inhibitors resisted 32% less force, absorbed 41% less energy, and were 21% more
lax than ligaments in control animals with the same injuries. One study investigating the
repair of tendinous injuries in rats found that COX-2 inhibitor injections given during the
14

first five days following initial injury resulted in a 27% reduction in ultimate force and
25% reduction in ultimate failure stress compared to rats not treated with NSAIDs
(Virchenko, Skoglund, & Aspenberg, 2004). While studying the effects of NSAIDs on
the recovery of contractile function following damage-causing exercise, Lapointe et al.
(2002) found that rats treated with NSAIDs experienced a significantly greater deficit in
muscular tetanic tension compared to placebo-treated rats. Studies on bone injuries in
mice have found that COX-2 inhibition is responsible for significantly reduced
ossification during fracture repair when compared to controls (Brown, Saunders, Kirsch,
Donahue, & Reid, 2004; Simon, Manigrasso, & O’Connor, 2002; Zhang et al., 2002;) and
decreased fracture site mechanical strength return (Endo et al., 2002; Gerstenfeld et al.,
2003; Simon et al., 2002).
Explanations for the negative outcomes in studies investigating the healing
processes of bones, muscles, tendons, and ligaments require careful consideration of the
mechanism of action of NSAIDS. NSAIDs inhibit the binding of COX, which reduces
the amount of inflammation-causing PGs produced (Warden, 2005). PGs have been
shown to stimulate skeletal muscle protein synthesis, thus COX activity may be
necessary for full skeletal muscle adaptation to overload (Warden, 2005). Because of
this, NSAID use may inhibit the normal hypertrophic response to resistance training
(Trappe et al., 2002). PGs also play an important role in bone homeostasis (Vuolteenaho,
Moilanen, & Moilanen, 2007); therefore altering PG synthesis can have an impact on
proper bone healing (Ziltener et al., 2010).
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Several studies have shown positive effects when NSAIDs were used in addition
to standard rehabilitation techniques in the treatment of ligament injuries; however, it is
believed that while the decreased pain from NSAID use may allow an earlier return to
training, the athletes ultimately have decreased stability and a decreased range of motion
at the site of injury (Slayter et al., 1997). This leads to the question of whether NSAID
use could also suppress the adaptive response of skeletal muscle connective tissue to
exercise (Mackey et al., 2012). While the data from human studies exploring the
potential of NSAIDs to limit muscle adaptation to resistance training is not clear (Trappe
et al., 2011), NSAID ingestion has been reported to suppress the protein synthesis
response in young individuals after a single bout of exercise (Trappe et al., 2002).
Furthermore, one animal study investigating the effects of NSAIDs on resistance training
found a 50–75% blunting of muscle hypertrophy in animals treated with NSAIDs (Soltow
et al., 2006).
Recent studies have focused on satellite cells and their interaction with NSAIDs.
Satellite cells are considered muscle “stem cells” because they have the capacity to repair
damaged tissue and replenish their own cell pool (Mackey, 2013). Satellite cells are also
very important for skeletal muscle adaption to exercise, they provide new myonuclei and
repair damaged myofibers, which is crucial for successful regeneration following injury
or exercise-induced muscle damage (Hawke & Garry, 2001; Schultz & McCormick,
1994). Studies have shown that COX enzymes are necessary for satellite cell activity
(Mendias, Tatsumi, & Allen, 2004) and muscle regeneration (Almekinders & Gilbert,
1986), inhibition of COX through the use of NSAIDs suppresses these functions and
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decreases the mixed muscle protein synthesis rates normally observed following exercise
(Trappe et al., 2002). Mackey et al. (2007) studied satellite cell activity during exercise
and post-exercise via muscle biopsy. Their results suggest that ingestion of NSAIDs
decreases satellite cell activity and therefore myogenesis and regeneration. Given the
important role satellite cells have in skeletal muscle maintenance and regeneration, any
substances that alter satellite cell activity (like NSAIDs) could inhibit the anabolic effects
exerted by exercise (Mackey et al., 2007; Mackey, 2013).
Gastro-intestinal (GI) complications have been shown to occur within one to three
months of chronic NSAID use (Gabriel, Jaakkimainen, & Bombardier, 1991). Risk
factors related to GI bleeding and NSAID use are bleeding abnormalities, age, history of
ulceration, smoking, alcoholism, chronic NSAID use, simultaneous NSAID use, and
consumption of large doses of NSAIDs (Lanier, 2004). Consumption of large doses of
NSAIDs may be a greater risk factor to larger athletes as larger doses (1500-1800
mg/day) are required to produce anti-inflammatory effects (Lanier, 2004). Van Wijck et
al. (2012) found that gastroduodenal and small intestinal permeability increased after
cycling in subjects that were given ibuprofen prior to exercise. This study also found a
clear relation between exercise-induced intestinal injury and small intestinal permeability
after exercise. It demonstrated that the use of ibuprofen before exhaustive exercise
exacerbates exercise-induced small intestinal injury and initiates gut barrier dysfunction
in healthy endurance athletes.
Why NSAID consumption leads to GI damage and increased risk of upper GI
complications has yet to be fully understood (Van Wijck et al., 2012). It is believed that
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COX is important in GI function, and therefore the inhibition of COX results in local
inflammation and vascular dysregulation, therefore reducing gastric perfusion and
compromising mucosal integrity within the splanchnic area (Crofford, 1997; Rodriguez
& Tolosa 2007). In addition, mucosal blood flow may by reduced due to the interference
of NSAIDs with PGs (Martin, Jimenez, & Motilva, 2001), this NSAID-induced reduction
of blood flow may deteriorate splanchnic hypoperfusion, putting athletes at risk for
serious GI complications (Van Wijck et al., 2012).
The National Kidney Foundation estimates that 10% of kidney failure is caused
by overuse of NSAIDs (Joslin et al., 2013). Diminished renal function occurs with
chronic use of NSAIDs however, acute renal failure can occur within 30 days of
continuous use (Huerta, Castellsague, Varas-Lorenzo, & Rodriguez, 2005). Also, renal
damage has been reported in athletes taking NSAIDs during exercise (Walker, Fawcett,
Flannery, & Gerrard, 1994); this damage can be life-threatening in excessive heat
(Griffiths, 1992). NSAIDs can have other adverse renal effects such as acute interstitial
nephritis, nephrotic syndrome, membranous nephropathy, and chronic kidney disease
(Huerta et al., 2005). Additionally, renal blood ﬂow may be reduced up to 75% of
normal levels during exercise; increased renal permeability during exercise along with
dehydration leads to this phenomena (Baker et al., 2005). Furthermore, the increase in
glomerular pressure and sodium retention caused by NSAIDs in combination with
decreased blood flow due to exercise may further increase the effects of NSAIDs on
athletes’ renal function (Baker et al., 2005).
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Two major risks have been identified with using NSAIDs during endurance
events: development of renal complications and exercise-associated hyponatremia (EAH)
(Joslin et al., 2013). NSAIDs reduce PG synthesis in the kidney, causing a decrease in
the rate of glomerular filtration and afferent renal blood flow (Baker et al., 2005; Warden,
2010). This combination of symptoms can impair an athlete’s free water clearance,
which increases the risk of developing renal disease and/ or EAH (Baker et al., 2005;
Page, Reid, Speedy, Mulligan, & Thompson, 2007). Furthermore, recent cases of renal
failure in high profile basketball players has brought into question whether NSAIDs
accelerate the onset of kidney disease (Holmes et al., 2013).
Recent studies and reviews of the effects of NSAIDs on the cardiovascular system
have found links between certain COX inhibitors and increases in cardiac mortality and
morbidity (Baron et al., 2008; Bavry et al., 2011; Couzin, 2004; Fitzgerald, 2004; Frantz,
2004; Graham et al., 2005; Mamdani et al., 2004; Trelle et al., 2011; Warden, 2005).
Other recent evidence suggests that NSAIDs may significantly increase the risk of
congestive heart failure in people with prior history of heart disease (Page & Henry,
2000), which occurs due to an increase in vascular resistance due to interference with
other medications such as aspirin and ACE inhibitors used to treat heart conditions
(Lanier, 2004).
Guidelines for Use
It is important to recognize that the prevalence of NSAID use in athletes has been
too high and has resulted in many adverse events. However, NSAID use should not be
shunned completely because it is potentially helpful in many common sports medicine
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scenarios (Paoloni et al., 2010). The prescribing of NSAIDs should be cautious with
careful consideration to both dose and duration and combined with other therapeutic
modalities such as ice and rehabilitation (Joslin et al., 2013; Paoloni et al., 2010; Warden,
2009; Ziltener et al., 2010). It is recommended that NSAIDs be used in an approach
where simple pain relief is the goal of treatment (Paoloni et al., 2010). Additionally, due
to the fact that NSAIDs inhibit the inflammatory process and therefore may be
detrimental to long-term healing, it is recommended that NSAID use be restricted to the
acute or sub-acute phases (up to 1 week) of injury repair (Lapointe, Fremont, & Cote,
2003; Warden, 2009).
Using NSAIDs during the sub-acute phase of injury, may have beneficial effects
(Brickson et al., 2003) by limiting edema, myotube and capillary regeneration (Thorsson,
Rantanen, Hurme, & Kalimo, 1998), and maintaining tensile and contractile strength
(Obremsky, Seaber, Ribbeck, & Garrett, 1994). However, NSAID use may cause
decreased tissue regeneration and increased fibrosis in the latter stages of healing and is
therefore contraindicated (Thorsson et al., 1998).
Reports on the use of topical NSAIDs have begun to show promise as a safer
alternative to orally administered NSAIDs. Topical NSAIDs deliver medication
subcutaneously to a localized site of injury making them effective at treating minor
injuries (Galer, Rowbotham, Perander, Devers, & Friedman, 2000; Singh & Roberts,
1994). Moore, Tramer, Carroll, Wiffen, and McQuay (1998) conducted a systematic
review of randomized controlled trials (RCTs) and concluded that topical NSAID use
was effective at relieving pain without serious adverse reactions. Akermark and
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Forsskahl (1990) performed a placebo-controlled, double-blind trial on the effects of
topically and systemically administered NSAIDs. Their results favored the use of topical
NSAIDs in superficial overuse injuries in athletes.
It has also been reported that using acetaminophen for pain reduction may be a
better alternative to NSAIDs, due to its milder effect on the GI tract, kidneys, and tissue
regeneration (Rahusen et al., 2004). Reports suggest that acetaminophen’s pain-relieving
capabilities may be comparable to those of NSAIDs (Rahusen et al., 2004).
Future Research/Recommendations
It is important to increase the awareness and education of medical professionals
and athletes about the potential adverse effects of NSAIDs and to recommend that these
medications be used in the presence of a clearly indicated medical condition (Alaranta et
al., 2008; Holmes et al., 2013; Lanier, 2004; Van Wijck et al., 2012). Specifically,
athletes require education that NSAIDs are principally indicated as short-term adjuncts
for the alleviation of acute pain and inflammation during rehabilitation and injury. This
means NSAIDs should not be used prophylactically (in the absence of injury) and that
they do not represent a “cure-all” or a substitute to physical therapy (Warden, 2009).
Finally, Holmes et al. (2013) states a need for longitudinal studies in more generalizable
athlete populations in order to determine the true risks associated with NSAIDs and
athletics.
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Chapter 3
Methods
General Overview
This study was intended to investigate prevalence of use, behaviors, and attitudes
associated with NSAIDs in a sample of collegiate athletes. The subjects used for this
study were student-athletes attending Portland State University (PSU). PSU is an NCAA
Division I institution that sponsors approximately 300 NCAA Division I student athletes
participating in 13 different sports. The specific sports teams at PSU are men’s football,
basketball, tennis, cross-country, and track, and women’s basketball, softball, tennis,
cross-country, track, golf, soccer, and volleyball.
Data were collected with a questionnaire developed to gather information about
NSAID use among the student-athletes. Surveys asked participants to provide
demographic information and information about their NSAID-related behaviors. Study
participants were volunteers who met specific eligibility criteria (see Eligibility
Requirements below). Data collection took place throughout a 4-week period. Data were
collected by hand and input into a spreadsheet for descriptive analysis.
Subjects
This study investigated the student-athlete population of PSU, which was
comprised of 291 NCAA Division I student-athletes during the time of this study. PSU
has 13 NCAA men’s and women’s collegiate sports, which include men’s football (n =
97), men’s basketball (n = 17), men’s tennis (n = 8), men’s cross-country (n = 12), and
men’s track (n = 26), women’s basketball (n= 14), women’s softball (n = 19), women’s
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tennis (n = 9), women’s cross-country (n = 11), women’s track (n = 31), women’s golf (n
= 6), women’s soccer (n = 30), and women’s volleyball (n = 11).
Eligibility Criteria
In order to participate in this study, athletes had to be: (1) currently enrolled
students at PSU, (2) currently on their team’s roster, (3) participating at the varsity-level,
(4) participating in an NCAA-sponsored sport, (5) and be at least 18 years of age.
Data Collection
All data collection was performed at the Peter Stott Center, located on PSU’s
main campus. The Peter Stott Center is the main sports complex at PSU, housing all
athletic teams and athletes.
This study used an original, hard-copy questionnaire to collect data regarding
athletes’ use, behaviors, and knowledge related to NSAIDs. The questionnaire was
administered in paper form with the goals of increasing participation and minimizing
non-compliance that can occur with an electronic survey. Questions for this survey were
compiled from previously published research studies. Questions were refined through
pilot testing and discussion with sports medicine professionals familiar with college
athletes and NSAIDs. Questions were written in a neutral manner so that subjects did not
feel coerced to answer questions in a certain manner. Questions were answered in “yes”
or “no” fashion, as well as “check one” or “check all that apply.” This was done to
minimize the burden of answering long questions and increase the participation rate.
Questionnaires were administered for approximately four weeks in an attempt to
survey as many athletes as possible. Athletes were approached by the researcher and
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asked if they would be willing to participate in the study. Athletes agreeing to participate
were allowed to complete the questionnaire at their leisure and place of choosing.
Subjects returned completed to the researcher (either immediately if they completed the
survey in-person, or by appointment if they took the survey home) who then placed the
completed document in a sealable folder. Surveys were handled only by the researcher
and stored in a locked file cabinet located in the Peter Stott Center athletic training room.
Athletes who did not complete surveys within the 4-week period were excluded from the
study.
Consent for this study was implied (i.e., completion of a questionnaire by a
participant implied that they consented to have their data used in this study). This
method was applied in order to limit the amount of identifiable information participants
provided. Implied-consent forms were attached to the front of each questionnaire and
read by the participant before completing the survey. Consent forms detailed the purpose
and risks involved in study participation, and also provided contact information if they
wished to follow-up after the study was completed. Participants were encouraged to ask
any questions they had before participating in the study.
The beginning of the survey instrument provided instructions on how to answer
the questions. After reading the introduction, participants were asked to provide
demographic information (i.e., date of birth, gender, year of eligibility, and sport). The
remainder of the questionnaire contained 16 questions about their personal history of
NSAID use as well as their current behaviors and attitudes towards NSAID use.
Questions began by asking about the participant’s general history of use (e.g., “Have you
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taken NSAIDs before in your lifetime?”, “When did you start taking NSAIDs?”). The
next set of questions asked participants about their NSAID use behaviors (e.g., “Do you
take NSAIDs in-season or out-of-season?”, “Do you use NSAIDs daily, monthly, or
yearly?”). The final set of questions asked subjects about their attitudes and knowledge
about NSAIDs (e.g., “What are your reasons for taking NSAIDs?”, “Are you aware of
any adverse side-effects caused by NSAID?”). (See Appendix A for Survey Instrument)
Variables
The variables investigated in this study were based around demographic
information, knowledge, attitudes, and behaviors related to the use of NSAIDs by
collegiate athletes. Age, gender, year of eligibility, and sport were measured so that
comparisons of NSAID use could be made. Participants were asked about their history of
NSAID use: “Have they ever taken NSAIDs?”, “When did they first take NSAIDs?”,
“How often have they taken NSAIDs since they first started using them?”; “Who
influenced them to start taking NSAIDs”, and “Why did they start taking NSAIDs”.
Answers to these questions allowed the researcher to compile information on prevalence
of use, consistency of use, and reasons for use.
Participants were also asked about their attitudes and behaviors towards NSAIDs,
specifically in relation to their sport: “Are you currently taking NSAIDs for reasons
related to your sport?”, “How often do you use NSAIDs while competing in-season?”,
How about while training in the off-season?”, “What are your reasons for taking NSAIDs
while competing in-season?”, “What are your reasons for taking NSAIDs during the offseason?”, and “How do you primarily receive your NSAIDs?”. Answers to these
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questions helped the researcher determine if the athletes use NSAIDs with higher
amounts of physical activity, under supervision, chronically, and for reasons indicated or
contraindicated by research.
Participants were finally asked general questions about NSAIDs: “What is a
typical dose of NSAIDs you take at a given time?”, “Are you aware of any side-effects
caused by NSAIDs?”, and “Have you ever experienced any side-effects during sportsrelated activity you believed were caused by using NSAIDs?”. Answers to these
questions helped the researcher assess the participants’ basic knowledge about and
experience with NSAIDs, specifically dosage and side-effects.
Data Analysis
At the end of the 4-week sampling period, data from the questionnaires were
manually input into a Microsoft Excel spreadsheet. Data were then compiled and simple
descriptive statistics were calculated (e.g., means, standard deviations, percentages). The
data were organized into tables and figures, which are presented in the results section.
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Chapter 4
Results
A total of 79 PSU student-athletes completed questionnaires. Table 1 shows that
of the 79 participants; 54 were male, most of whom were football players (n = 44), and
25 were female. It should be noted that data were collected from 9 sports teams, 3 of
which were male sports teams (football, basketball, and cross country/track & field) and
6 of which were female sports teams (cross country/track & field, basketball, softball,
volleyball, tennis, and soccer).
Table 1. Subject Descriptive Data
n

Male

Female

Total

54

25

79

Age (yr)

Sport (n)

Eligibility (n)

20.7 ± 1.3

FB - 44
BSKB - 3
CCTF - 7

FR - 9
SO - 13
JR - 19
SR - 13

19.9 ± 1.3

CCTF - 5
BSKB - 3
SB - 3
VB - 4
TEN - 3
SOC - 7

FR - 9
SO - 4
JR - 8
SR - 4

20.5 ± 1.3

FB - 44
BSKB - 6
CCTF - 12
SB - 3
VB - 4
TEN - 3
SOC - 7

FR - 18
SO - 17
JR - 27
SR - 17

n = sample size, FB = Football, BSKB = Basketball, CCTF = Cross Country Track & Field, SB =
Softball, VB = Volleyball, TEN = Tennis, SOC = Soccer, FR = Freshman, SO = Sophomore, JR =
Junior, SR = Senior. (mean ± sd)
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The survey response data for all questions can be found in Appendix D. Total
sample data (n; %) are located in the first two columns, while data for males and females
are located in columns 3-4 and 5-6, respectively. Responses to each question are grouped
together and separated by alternating white and grey background. It should be noted that
100% of the athletes that participated in this study reported a history of NSAID use at
some point in their lifetime.
Figure 1 depicts the summary of responses to question 2 (“When did you first use
NSAIDs?”). Based on these results it appears that the majority of the athletes started
taking NSAIDs before high school (72% of the males and 64% of the females started pre
high school). A large percentage of males (39%) and females (44%) started taking
NSAIDs even before middle school, which indicates that many of these athletes first used
NSAIDs well before their teenage years. Although there were twice as many males as
females, 16% of the females started taking NSAIDs in college, compared with only 2%
of the males. These data indicate that females are more likely to start taking NSAIDs
later than males.
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Summary of responses to question 2 (“When did you first use NSAIDs?”).

Figure 2 shows the percentage of athletes that were currently (within the past
week) taking or not taking NSAIDs at the time of this study. Data were obtained from
question 5 (“Are you currently taking any NSAIDs?”). Also shown in Figure 2 is the
percentage of athletes currently taking NSAIDs that were following a prescription. The
data were obtained from question 6 (“Are you currently taking NSAIDs that were
prescribed to you by a doctor or medical professional (Physical therapist, Athletic
trainer, etc.)?” At the time of this study, 33% of males and 32% of females reported that
they had been taking NSAIDs within the past week. Of the athletes that were currently
taking NSAIDs, only half (16%) of the females and approximately one-third (9%) of
males reported to be using NSAIDs that were prescribed to them by a health care
professional. Based on these data, it appears that both male and female athletes in this
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sample may be more likely to use NSAIDs independently (without prescription from a
health care professional).
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Current Use YES

Current Use NO

Current Presc. YES

Figure 2. Summary of responses to question 5 (“Are you currently taking any
NSAIDs?”) and question 6 (“Are you currently taking NSAIDs that were
prescribed to you by a doctor or medical professional (Physical therapist,
Athletic trainer, etc.)?”

Figure 3 shows the summary responses to question 8 (“How often do you use
NSAIDs while competing IN-SEASON?”) and question 9 (“How often do you use NSAIDs
while training in the OFF-SEASON?”). The frequency of NSAID use while athletes were
in-season (IS) or off-season (OS) was categorized as frequently (3-7 days per week),
regularly (1-2 days per week), infrequently (1-3 times per month), and never. Frequent
use and regular use are considered to be high NSAID use, and the responses were
combined. Infrequent use is considered to be low NSAID use. High in-season use of
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NSAIDs was reported by 52% of the male athletes and 48% of the female athletes,
whereas off-season use was reported in 21% and 12% of the males and females,
respectively. In males, the percentage of athletes reporting low use in-season (33%) was
nearly identical to those reporting low use off-season (32%). A similar finding was noted
for female athletes reporting low use in-season (40%) and off-season (44%). Fifteen
percent of the male athletes reported never using NSAIDs in season, while 7% reported
never using NSAIDs off-season. The percentages of female athletes that reported never
using NSAIDs were 12% in-season and 16% off-season.
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Figure 3. Summary of responses to question 8 (“How often do you use NSAIDs while
competing IN-SEASON?”), and question 9 (“How often do you use NSAIDs
while training in the OFF-SEASON?”). High = “Frequently” + “Regularly”;
Low = “Infrequently”
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Based on these data it appears that high NSAID use in-season is greater than high
NSAID use off-season in both male and female athletes. Low NSAID use in both males
and females appears to be similar in-season and off-season. It is also apparent that more
athletes use NSAIDs than those that do not. One answer not included in Figure 3 was the
option “rarely” (off-season NSAID use only a few times per year). This option was not
provided for the question regarding in-season use because the usual duration of
competition is rarely longer than several months. Males reported rare NSAID use during
the off-season (41%), whereas 28% of the females reported rare use during the offseason. If off-season low NSAID use is defined as a combination of athletes reporting
rare NSAID use during the off-season and athletes reporting infrequent use during the
off-season, the percentage of males reporting low NSAID use is 73% and the percentage
of females reporting low NSAID use is 72%. This is a large percentage of athletes
reporting low NSAID use during the off-season, which contrasts with the high NSAID
use in-season use (males: 52%; females: 48%). These data suggests that the high NSAID
use when athletes are in-season is due to the increased rigors of in-season competition.
Figure 4 shows summary responses to question 10 (“What are your reasons for
using NSAIDs while competing IN-SEASON?”) and question 11 (“What are your reasons
for using NSAIDs while training in the OFF-SEASON?”). For this question athletes were
asked to “choose all that apply,” which is why percentages total greater than 100%. The
main reason given for both in-season and off-season NSAID use was for relief of pain
due to injury (in-season: 76% male, 72% female; off-season: 57% male, 64% female).
Other reasons included preventing injury or pain (in-season: 24% male, 36% female; off32

season: 17% male, 20% female), soreness (in-season: 63% male, 40% female; off-season:
48% male, 32% female), recovery (in-season: 37% male, 20% female; off-season: 24%
male, 12% female), and tightness (in-season: 24% male, 20% female; off-season: 17%
male, 20% female). Athletes were also given the option to select “no NSAID use” inseason and off-season. No in-season NSAID use was reported by 11% of the males and
4% of the females. No off-season NSAID use for males and females was 20% and 8%,
respectively.
Reasons for NSAID use IS vs. OS seem to be similar with males and females.
The most notable gender disparities between answers responses appear to be between IS
soreness (23% difference), OS soreness (16% difference), and IS recovery (17%
difference). While there is no obvious reason why these answers were largely different
between males and females, some simple answers may be that males and females
interpreted soreness differently, or males simply had more responses due to their larger
sample size. There is a noticeable decline in answers when comparing IS responses to
OS responses in both males and females. This data may further suggest that NSAID use
IS is higher than NSAID use OS.

33

100%
90%

Male

Female

80% 76%
72%

Response Frequency (%)

70%

64%

63%

57%

60%

48%

50%

40%

40%

37%

36%
32%

30%

24%

24%
20%

20%
17%

20%

24%
20% 20%
17%

12%

10%
0%
IS

OS

P! Relief Inj.

IS

OS

Prevention

IS

OS

Soreness

IS

OS

Recovery

IS

OS

Tightness

Figure 4. Summary of responses to question 10 (“What are your reasons for using
NSAIDs while competing IN-SEASON?”) and question 11 (“What are your
reasons for using NSAIDs while training in the OFF-SEASON?”).

Figure 5 shows the summary responses to question 12 (“From whom do you
PRIMARILY receive your NSAIDs?”). The majority of athletes (59% male; 52% female)
appear to primarily obtain their NSAIDs through self-purchasing, presumably at popular
retail stores. Athletes also reported obtaining NSAIDs from family members (22% male;
16% female) and athletic trainers (15% male; 20% female). Very few athletes reported
that they primarily obtain their NSAIDs from peers, coaches, or doctors.
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In total, 83% of males and 76% of females reported that they obtain their NSAIDs
primarily through means outside of health-care professionals, which further suggests a
high amount of independent use and self-medication.
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Figure 5. Summary of responses to question 12 (“From whom do you PRIMARILY
receive your NSAIDs?”).

Figure 6 illustrates summary responses to question 13 (“How do you TYPICALLY
determine the dose of NSAIDs to take at a given time?”). Forty-one percent of the male
athletes and 44% of the female athletes reported that they take doses of NSAIDs based on
what the directions tell them to take. Some athletes indicated that the typical dose was
determined on the basis of directions provided by athletic trainers (20% male; 24%
female). Others reported that the typical dose was based on the amount of pain and
soreness experienced (28% male; 28% female). Only 4% of the male athletes and 4% of
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the female athletes reported that the direction of a physician was used in determining a
typical dose of NSAIDs.
Most athletes reported determining a NSAIDs based on the directions
(presumably on the bottle label) or based on the level of pain and soreness they
experienced (69% male; 68% female), therefore it can be assumed that they are using
NSAIDs from a self-purchased bottle. While this is not a certainty, most NSAIDs
dispensed by health-care professionals are in packet form as a single dose; therefore,
dosage instructions are not necessary. This data further suggests independent and
indiscriminate use of NSAIDs by athletes without supervision.
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Figure 6. Summary of responses to question 13 (“How do you TYPICALLY determine
the dose of NSAIDs to take at a given time?”).

Figure 7 shows the summary of responses to question 15 (“Have you heard of
NSAIDs causing any side effects?”). An overwhelming majority of athletes (83% male;
76% female) were not aware of any side-effects from taking NSAIDs. Only 17% of male
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athletes and 24% of female athletes were aware of any side-effects from taking NSAIDs.
These data suggest that most athletes are taking NSAIDs unaware of any associated risks.
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Figure 7. Summary of responses to question 15 (“Have you heard of NSAIDs causing
any side effects?”).
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Chapter 5
Discussion
This study was performed to investigate NSAID use in Division I collegiate
athletes. To date, few studies in this population have been published, and the results of
this study add to the body of knowledge about NSAID use in collegiate athletes. In one
recent study, Holmes et al. (2013) investigated the prevalence of NSAID use among
collegiate football players and found that 95.7% had used NSAIDs at some point in their
lives. The current study supports these findings with 100% of athletes reporting NSAID
use at some point in their life. Holmes et al. (2013) also reported a high percentage of
early NSAID use in which athletes reported first using NSAIDs as early as middle school
(45.6%). Athletes from the current study also reported a significant percentage of early
NSAID use, with the majority of athletes reporting NSAID use as early as elementary
school (37% male; 40% female). Additionally, athletes in the Holmes et al. (2013) study
reported obtaining NSAIDs from a variety of sources, the majority (81%) of whom
reported that they obtained NSAIDs through self-purchasing. Although the current study
differed from the Holmes et al. (2013) study by asking athletes about their primary
sources of NSAIDs rather than all of the sources, there were similar findings in which the
majority of athletes (59% of males; 52% of females) reported self-purchasing as their
primary method of obtaining NSAIDs.
Finally, Holmes et al. (2013) found that 50% of athletes reported high (daily or
weekly) NSAID use in-season compared to 14.6% reporting high NSAID use during the
off-season. The current study provided similar findings, with 52% of male athletes and
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48% of female athletes reported high NSAID use in-season compared with 21% of male
athletes and 12% of female athletes who reported high off-season NSAID use. Both
studies found a higher percentage of high use of NSAIDs when athletes are in-season and
a lower percentage of high-use when they are off-season. Both studies also appear to
have found a high percentage of athletes starting NSAID use at an early age while also
obtaining the majority NSAIDs from sources other than health care professionals.
The current study found that 33% of males and 32% of females had been taking
NSAIDs within the past week, while only 16% of the females and 9% of males reported
using NSAIDs that were prescribed to them. This suggests that male and female
collegiate athletes may be predisposed to use NSAIDs without prescription from a health
care professional. As previously mentioned, a large percentage of both male and female
athletes reported high-use of NSAIDs in-season while reporting high amounts of low to
minimal-use off-season. Based on these data and previous studies, it appears that both
male and female athletes are likely using NSAIDs at increased frequencies in-season due
to the increased rigors of in-season training and competition. This notion was further
supported when athletes were asked about the reasons they use NSAIDs in-season and
off-season.
Athletes reported that their main reason for in-season and off-season NSAID use
was for pain relief due to injury, but also reported high response rates for prophylactic
use, DOMS, recovery, and general muscle tightness. Response rates for each option were
higher in-season than off-season, which may further support higher in-season use of
NSAIDs due to the increased physical demands of in-season competition. This
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information also demonstrated that athletes are likely using NSAIDs outside of their
intended use.
Study reviews on proper NSAID use guidelines (Warden, 2009; Ziltener et al.,
2010) seem to agree that short-term (less than 7 days) use of NSAIDs in the presence of
certain injuries can be effective in the treatment of pain and inflammation without highrisk of experiencing adverse events. While this may be true, many of the athletes in this
study reported high-use of NSAIDs for the duration of their entire sports seasons, thus
putting them at an increased risk of experiencing adverse events (Gabriel, Jaakkimainen,
& Bombardier, 1991; Huerta et al., 2005; Lanier, 2004). Although taking NSAIDs
prophylactically and for recovery may seem like a logical strategy to many athletes, there
is no definitive literature supporting or refuting the use of NSAIDs for delayed-onset
muscle soreness (DOMS). Much of the literature, however, contraindicates prophylactic
use of NSAIDs (Alaranta et al., 2008; Baker et al., 2005; Joslin et al., 2013; Van Wijck et
al. 2012; Warden, 2009).
Additionally, this study found that the majority of athletes (83% male; 76%
female) were not aware of any side-effects of NSAID use, suggesting that many athletes
are taking NSAIDs unaware of any associated risks. Most of the athletes in this study
reported that they obtain their NSAIDs primarily through means outside of health-care
professionals and reported taking doses based on the level of pain and soreness they
experienced. These data further suggest independent and indiscriminate use of NSAIDs
by athletes without supervision. These findings, combined with a high amount of high-
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use of NSAIDs for reasons outside of their intended use, may further increase the risk of
adverse events.
Another goal of this study was to investigate NSAID use by gender and sport.
Behaviors and attitudes around NSAID use were very similar between male and female
athletes in this study. However, there were several gender differences of note. Despite
there being twice as many male participants as female athletes, 16% of the female
athletes started taking NSAIDs in college compared to 2% of the male athletes. This
suggests that female athletes start taking NSAIDs later in their athletic careers. Another
gender difference appeared to be in the athletes’ reasons for NSAID use: IS soreness
(males: 63%; females: 40%), OS soreness (males: 48%; females: 32%), and IS recovery
(males: 37%; females: 20%). While there is no apparent reason for this difference, it may
be because males and females interpreted soreness differently.
Unfortunately, this study was unable to obtain enough data to make inferences
about sport-specific NSAID use. However, because football players represented a
substantial proportion of the sample (44 out of 79 participants), the current study provides
potentially useful information about NSAID use in football players. Similar to the
Holmes et al. (2013) study, the current study found a high prevalence of high-use of
NSAIDs. Of the 44 football players, 13 (30%), reported current (within the past week)
use of NSAIDs, while only 5 (11%) of the players reported to have been prescribed
NSAIDs. In-season use of NSAIDs was high in 21 (48%) of the players, but in only 6
(14%) of the players during the off-season, again showing a common trend in high
prevalence of high use in-season compared to a low prevalence of high use off-season.
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Also in line with the Holmes et al. (2013) study, 80% of players reported that they
obtained NSAIDs from sources other than health-care professionals; indicating a
likelihood of indiscriminate and unsupervised use. Finally, 89% of the football players
were unaware of any side-effects of NSAID use, indicating a general lack of knowledge
of NSAIDs.
Limitations
This study had several limitations that should be noted. It was a cross-sectional
survey, and was limited to a convenience sample of participants. Also, the extent to
which participants may have answered questions in a socially desirable manner is not
known. However, all participants were encouraged to respond to questions truthfully.
Because this study took place at a single institution over a short period of time, the results
may not be generalizable to other institutions or populations. It is also possible that the
results to this study may not be generalizable simply due to a relatively small sample size.
It was originally thought that data could be obtained from all 291 student-athletes via
team meetings. However, due to the timing of this study, most sports teams were offseason and it was difficult to arrange data collection on a group basis. Therefore, athletes
were contacted individually to complete the surveys.
Conclusion
In summary, this study revealed a pattern of high NSAID use in athletes
competing in-season compared to high amounts of low NSAID use in athletes off-season.
It also revealed a high amount of non-prescription NSAID use. There was a high
prevalence of self-purchasing of NSAIDs, combined with self-medication. Furthermore,
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athletes demonstrated a long history of NSAID use, with a majority of athletes reporting
that they began using NSAIDs well before high school. This study also revealed a
general lack of knowledge about NSAIDs as most athletes reported taking these drugs for
reasons outside their intended use and without much awareness of potential side-effects.
Future studies should be conducted in a longitudinal manner to more clearly
understand the true prevalence of NSAID use in athletes. More studies need to be
performed on larger samples with diverse athlete populations. This would help provide a
deeper understanding of potential differences in NSAID use between genders, sports, and
social backgrounds. Finally, additional research could help to increase the awareness and
education of athletes and their health-care professionals about the proper use and
potential negative effects of NSAIDs.
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Appendices
Appendix A. Survey Instrument

NSAID Use in Collegiate Athletes
Dear Participant,
Thank you for your willingness to partake in this research study. Please read
questions carefully as some of them ask you to provide more than one answer.
Also, when answering questions, please notice that some answer options have
carried over to another page. Again, the information you provide is completely
confidential and will not be used outside of this study, so please answer
questions as accurately and honestly as possible. When finished with the survey
please turn it in to the envelope at the front of the room. If you have any
questions please feel free to ask at any time.
Thank you,
Brian Davis, ATC

Demographic Information
Age: _______ yrs

Gender (Circle one): Male / Female
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Year of Eligibility in Sport (Circle one): Freshman /
Sophomore / Junior / Senior

Primary Sport (Circle one): Football / Basketball / Tennis /
Cross Country and Track & Field / Softball / Volleyball / Golf
/ Soccer

Questionnaire
History of Use
1) Have you taken any NSAIDs in your lifetime? (Check all that apply. If you
have never taken any NSAIDs, please turn in your survey)
Drug Name/Category

Brand Name

____ Ibuprofen
____ Addaprin
____ Advil
____ Motrin
____ Naproxen
____ Aleve
____ Naprosyn
____ Anaprox
____ Naprelan
____ Acetylsalicylic Acid
____ Aspirin
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____ Coxib
____ Celebrex
____ Vioxx
*Combination*
____ Pain-Off
____ Back Pain-Off
____ Excedrin
____ Midol

Other: ____________________________________________________
_

I have never used NSAIDs (Please turn in your survey)

2) When did you first use NSAIDs? (Check one)
Pre-School
Elementary School
Middle School/Junior High School
High School
College
3) Why did you start taking NSAIDs? (Check all that apply)
Influence from parents or other family members
Influence from friends, teammates, or coaches
Instructed by a doctor or healthcare professional
Media influence (commercials, television, internet, etc.)
Other reasons: ___________________________________________
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4) How often have you taken NSAIDs since you first started using them?
Frequently (3-7 days per week)
Regularly/Occasionally (1-2 days per week)
Infrequently/Irregularly (Once or twice per month)
Rarely (Only a few times per year)
Never

Sport-Related Use
5) Are you currently (within the past week) taking any NSAIDs for reasons related
to your sport (i.e., injury, soreness, prevention, recovery, etc.)?
Yes
No

6) Are you currently (within the past week) taking NSAIDs that were prescribed
to you by a doctor or medical professional (physical therapist, athletic trainer,
etc.) for sports-related reasons?
Yes
No
7) Are you currently competing IN-SEASON with your sport? (This includes nontraditional seasons such as fall softball, spring football, summer basketball,
etc.)
Yes
No
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8) How often do you use NSAIDs while competing IN-SEASON? (Check one)
Frequently (3-7 days per week)
Regularly/Occasionally (1-2 days per week)
Infrequently/Irregularly (1-3 times per month)
Never
9) How often do you use NSAIDs while training in the OFF-SEASON? (Check
one)
Frequently (3-7 days per week)
Regularly/Occasionally (1-2 days per week)
Infrequently/Irregularly (Once or twice per month)
Rarely (Only a few times per year)
Never

Behaviors
10) What are your reasons for using NSAIDs while competing IN-SEASON?
(Check all that apply)
____I do not use NSAIDs during the season
Pain relief from injury
Preventing injury or pain
General soreness
Recovery
Muscle tightness
Increased energy
Less cramping
Other: _____________________________________________________
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11) What are your reasons for using NSAIDs while training in the OFF-SEASON?
(Check all that apply)
____I do not use NSAIDs during the off-season
Pain relief from injury
Preventing injury or pain
General soreness
Recovery
Muscle tightness
Increased energy
Less cramping
Other: ______________________________________________
12) From whom do you PRIMARILY receive your NSAIDs? (Check one)
Self-purchased
Parents
Teammates/Friends
Coaches
Athletic Trainers
Doctors
Other: _______________________________________________________

13) HOW do you typically determine the dose of NSAIDs to take at a given time
when doing sports-related activity? (Check one)
Whatever the directions tell me to take
Whatever my teammates tell me to take
Whatever the athletic training staff tells me to take
Whatever my doctor tells me to take
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I take doses based on how much pain or soreness I have
I take doses based on the amount of activity I will be doing
Other reasons: _______________________________________________
14) WHAT is the typical dose of NSAIDs you take at a given time for sportsrelated activity? (Check one)
____ 2 pills
____ 4 pills
____ 6 or more pills
____ 200 mg
____ 400 mg
____ 800 mg
____ Higher than 800 mg

General Information
15) Are you aware of any side-effects caused by NSAIDs? (If you answer YES,
please list any you know of)
No
Yes (Please list): ____________________________________
16) Have you ever experienced any side-effects during sports-related activity you
believed were CAUSED by using NSAIDs? (If you answer YES, please list any
you know of)
____ No
____ Yes (Please list): ___________________________________
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Appendix B. Consent Form
The Portland State University
Consent to Participate in Research
Non-Steroidal Anti-Inflammatory Drug Use in Collegiate Athletes
(v. 4/2/15)
You are being asked to participate in a research study that is being done by Brian Davis,
who is the student researcher, from the School of Community Health of the College of
Urban & Public Affairs at Portland State University. This research study is being
conducted to investigate non-steroidal anti-inflammatory drug (NSAID) use in collegiate
athletes. NSAIDs are common medications used for pain, inflammation, fever, and
injury. Most of these medications are available without a prescription in stores or
pharmacies. For these reasons, NSAIDs are frequently used by athletes to treat pain and
dysfunction associated with athletic events. Common brand names for these medications
include: ibuprofen, Advil, Aleve, Motrin, Addaprin, Midol, Aspirin, Naprosyn,
Toradol, Celebrex, and Vioxx.
Those who agree to participate in this study must be of 18 years of age, currently enrolled
at Portland State University, and an active player on their team’s roster. If you agree to
participate in this study you will be asked to fill-out a questionnaire, which asks questions
about your use of and knowledge of NSAIDs. Participants will also be asked to provide
their age, gender, and sport. The questionnaire will take approximately 5-10 minutes to
complete. Once the questionnaire has been completed and submitted, your participation
in this study will be completed and no further action will be needed of you.
Participation in this study will provide important data to the local sports medicine
community, which may allow for improvements in medication policies that will directly
benefit the athletes at Portland State University and other institutions in the area.
While this study is considered to have minimal risk, there is the possibility that
participants may experience stress, emotional distress, inconvenience, and/or loss of
privacy, if information provided was to be linked to a certain individual. However,
measures will be taken to protect the security of all information you provide. Names will
not be provided on questionnaires to minimize the potential for breaches in
confidentiality. Questionnaires containing any information from participants will be
handled only by the research team. Questionnaires will be administered in private and
secure environments. All questionnaires will be placed in sealable folders and kept in a
locked cabinet in a secure room. Information from questionnaires will be used solely for
the purpose of this research study, and no specific information will be provided to
coaches, teammates, or administrators. Results of this study will be shared only with the
sports medicine staff at PSU in order to evaluate and improve policies on medication use.
Information will be reported in aggregate (i.e., no single participant’s data will be
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shared). Data will be securely stored for three years, after which all questionnaires and
data forms will be shredded and discarded. These measures will be taken to protect the
security of all the information you provide, but we cannot guarantee confidentiality of all
study data.
Keep in mind that your participation in this study is completely voluntary. You have the
right to choose not to participate or to withdraw your participation at any point without
penalty.
If you have any questions, concerns or complaints at any time about the research study,
please contact Brian Davis at (206) 919-6867 or bdavi2@pdx.edu
If you need to contact someone else associated with this research study, please contact
Gary Brodowicz at bqgb@pdx.edu
If you have questions regarding your rights as a research participant, you may call the
PSU Office for Research Integrity at (503) 725-2227 or 1(877) 480-4400. The ORI is the
office that supports the PSU Institutional Review Board (IRB). The IRB is a group of
people from PSU and the community who provide independent oversight of safety and
ethical issues related to research involving human participants. For more information,
you may also access the IRB website at:
https://sites.google.com/a/pdx.edu/research/integrity
CONSENT
You are making a decision whether to participate in this study. Completion of the
questionnaire indicates your consent to participate in this research study.
Thank you for your time
-Brian Davis, ATC
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Appendix C. Human Subjects Approval

Post Office Box 751
Portland, Oregon 97207-0751
503-725-8170 fax
503-725-2227 tel
Human Subjects Research Review Committee: hsrrc@lists.pdx.edu
Date: April 24, 2015
To: Gary Brodowicz / Brian Davis
From: Karen Cellarius, HSRRC Chair
Re: HSRRC approval for your project titled, “Non-Steroidal Anti-Inflammatory Drug
Use in Collegiate Athletes” HSRRC Proposal # 153393
Review Type: Exempt, Category 2
In accordance with your request, the Human Subjects Research Review Committee has
reviewed your proposal referenced above for compliance with PSU and DHHS policies
and regulations covering the protection of human subjects. The Committee is satisfied
that your provisions for protecting the rights and welfare of all subjects participating in
the research are adequate, and your project is approved. Please note the following
requirements:
Approval: You are approved to conduct this research study after receipt of this approval
letter; and the research must be conducted according to the plans and protocol submitted
(approved copy enclosed).
Consent: Signed consent is waived from all participants in this study. A written consent
statement is required.
Changes to Protocol: Any changes in the proposed study, whether to procedures,
survey instruments, consent forms or cover letters, must be outlined and submitted to the
Committee immediately. The proposed changes cannot be implemented before they have
been reviewed and approved by the Committee.
Adverse Reactions and/or Unanticipated Problems: If any adverse reactions or
unanticipated problems occur as a result of this study, you are required to notify the
Committee immediately. If the issue is serious, approval may be withdrawn pending an
investigation by the Committee.
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Completion of Study: Please notify the Committee as soon as your research has been
completed. Study records, including protocols and signed consent forms for each
participant, must be kept by the investigator in a secure location for three years following
completion of the study (or per any requirements specified by the project’s funding
agency).
If you have questions or concerns, please contact the Office of Research Integrity in the
PSU RSP at 503-725-2227, 1600 SW 4th Ave., Market Center Building, Suite 620.
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Appendix D. Table 2. Survey Response Data
Table 2. Survey Response Data
Question

Total (n)

(%)

Male (n)

(%)

Female (n)

(%)

Used NSAIDs

79

100%

54

100%

25

100%

Not Used NSAIDs

0

0%

0

0%

0

0%

First use: Pre-School

2

3%

1

2%

1

4%

First use: Elementary

30

38%

20

37%

10

40%

First use: Middle School

25

32%

19

35%

6

24%

First use: High School

17

22%

13

24%

4

16%

First use: College

5

6%

1

2%

4

16%

Why Start: Family

58

73%

41

76%

17

68%

Why Start: Peers

25

32%

17

31%

8

32%

Why Start: Doctor

36

46%

21

39%

15

60%

Why Start: Media

3

4%

3

6%

0

0%

Why Start: Other

5

6%

4

7%

1

4%

Hx use Frequently

5

6%

3

6%

2

8%

Hx use Regularly

11

14%

9

17%

2

8%

Hx use Infrequently

34

43%

21

39%

13

52%

Hx use Rarely

28

35%

21

39%

7

28%

Hx use Never

1

1%

0

0%

1

4%

Currently Using YES

26

33%

18

33%

8

32%

Currently Using NO

53

67%

36

67%

17

68%

Currently Prescribed YES

9

11%

5

9%

4

16%

Currently Prescribed NO

70

89%

49

91%

21

84%

Sport In-Season YES

32

41%

10

19%

22

88%

Sport In-Season NO

47

59%

44

81%

3

12%

IS use Frequently

11

14%

8

15%

3

12%

IS use Regularly

29

37%

20

37%

9

36%
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IS use Infrequently

28

35%

18

33%

10

40%

IS use Never

11

14%

8

15%

3

12%

OS use Frequently

2

3%

2

4%

0

0%

OS use Regularly

12

15%

9

17%

3

12%

OS use Infrequently

28

35%

17

32%

11

44%

OS use Rarely

29

37%

22

41%

7

28%

OS use Never

8

10%

4

7%

4

16%

IS No use

7

9%

6

11%

1

4%

Reason: P! Relief Inj.

59

75%

41

76%

18

72%

Reason: Prevention

22

28%

13

24%

9

36%

Reason: Soreness

44

56%

34

63%

10

40%

Reason: Recovery

25

32%

20

37%

5

20%

Reason: Tightness

18

23%

13

24%

5

20%

Reason: Energy

5

6%

4

7%

1

4%

Reason: Cramping

7

9%

1

2%

6

24%

Reason: Other

4

5%

1

2%

3

12%

OS No use

13

16%

11

20%

2

8%

Reason: P! Relief Inj.

47

59%

31

57%

16

64%

Reason: Prevention

14

18%

9

17%

5

20%

Reason: Soreness

34

43%

26

48%

8

32%

Reason: Recovery

16

20%

13

24%

3

12%

Reason: Tightness

14

18%

9

17%

5

20%

Reason: Energy

2

3%

2

2%

0

0%

Reason: Cramping

3

4%

0

0%

3

4%

Reason: Other

6

6%

3

6%

3

12%

Receive: Self Purchased

45

57%

32

59%

13

52%

Receive: Family

16

20%

12

22%

4

16%

Receive: Peers

2

3%

1

2%

1

4%
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Receive: Coaches

0

0%

0

0%

0

0%

Receive: Athletic Trainer

13

16%

8

15%

5

20%

Receive: Doctors

1

1%

0

0%

1

4%

Receive: Other

1

1%

0

0%

1

4%

Dose: Directions

33

42%

22

41%

11

44%

Dose: Peers

0

0%

0

0%

0

0%

Dose: Athletic Trainers

17

22%

11

20%

6

24%

Dose: Doctors

3

4%

2

4%

1

4%

Dose: Based on P!

22

28%

15

28%

7

28%

Dose: Activity Level

0

0%

0

0%

0

0%

Dose: Other

4

5%

4

7%

0

0%

Take: 2 Pills

47

59%

27

50%

20

80%

Take: 4 Pills

18

23%

16

30%

2

8%

Take: 6+ Pills

0

0%

0

0%

0

0%

Take: 200 mg

1

1%

1

2%

0

0%

Take: 400 mg

4

5%

2

4%

2

8%

Take: 800 mg

6

8%

5

9%

1

4%

Take: 800+ mg

1

1%

1

2%

0

0%

Aware of SE YES

15

19%

9

17%

6

24%

Aware of SE NO

64

81%

45

83%

19

76%

Experienced SE YES

3

4%

3

6%

0

0%

Experienced SE NO

76

96%

51

94%

25

100%

Grey and white contrasting was used to separate questions. Each area of different contrast represents a
question (e.g. Aware of SE YES and Aware of SE NO is one question, whereas Experienced SE YES
and Experienced SE NO is a different question). Questions totaling more than 100% were "choose all
that apply" format and thus many participants responded with more than one answer. Questions below a
total of 100% were due to participants leaving the question blank. "First use" refers to when participants
first started taking NSAIDs, "Why start" refers to why participants started taking NSAIDs, "Reason"
refers to the reasons participants take NSAIDs related to their sport, "Receive" refers to where
participants mainly receive their NSAIDs, "Dose" refers to how participants typically determine a dose
of NSAIDs, "Take" refers to the typical dose of NSAIDs participants take. Hx = History, IS = In-season,
OS = Off-season, SE = Side Effects, P! = Pain.
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